{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:44:53Z","timestamp":1788324293374,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX0987"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0987"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072327"],"award-info":[{"award-number":["82072327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.biopha.2024.116264","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T01:54:44Z","timestamp":1707962084000},"page":"116264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Enhanced protective efficacy of an OprF\/PcrV bivalent DNA vaccine against Pseudomonas aeruginosa using a hydrogel delivery system"],"prefix":"10.1016","volume":"172","author":[{"given":"Yating","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2467-1544","authenticated-orcid":false,"given":"Linxia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoFeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9642-1883","authenticated-orcid":false,"given":"Jianglei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5009-2044","authenticated-orcid":false,"given":"Xian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.116264_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"issue":"2","key":"10.1016\/j.biopha.2024.116264_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cxo.12621","article-title":"Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective","volume":"101","author":"Subedi","year":"2018","journal-title":"Clin. Exp. Optom."},{"issue":"2","key":"10.1016\/j.biopha.2024.116264_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","article-title":"Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review","volume":"6","author":"Pachori","year":"2019","journal-title":"Genes Dis."},{"issue":"3","key":"10.1016\/j.biopha.2024.116264_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00668-18","article-title":"The impact of ExoS on Pseudomonas aeruginosa internalization by epithelial cells is independent of fleQ and correlates with bistability of type three secretion system gene expression","volume":"9","author":"Kroken","year":"2018","journal-title":"mBio"},{"issue":"13","key":"10.1016\/j.biopha.2024.116264_bib5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.116264_bib6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011-2014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.biopha.2024.116264_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2147\/IDR.S350976","article-title":"Ceftazidime\/avibactam versus Polymyxin B in the challenge of carbapenem-resistant Pseudomonas aeruginosa infection","volume":"15","author":"Chen","year":"2022","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"10.1016\/j.biopha.2024.116264_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ice.2019.296","article-title":"Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015-2017","volume":"41","author":"Weiner-Lastinger","year":"2020","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116264_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/etm.2020.9217","article-title":"Use of polymyxin B in patients with renal impairment: a retrospective examination of 5 cases","volume":"20","author":"Yu","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"8","key":"10.1016\/j.biopha.2024.116264_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/sur.2018.233","article-title":"Progress Toward the Elusive Pseudomonas aeruginosa Vaccine","volume":"19","author":"Merakou","year":"2018","journal-title":"Surg. Infect. (Larchmt. )"},{"issue":"7","key":"10.1016\/j.biopha.2024.116264_bib11","first-page":"589","article-title":"[Construction of recombinant Bb(pGEX-OprF-I) vaccine of Pseudomonas aeruginosa and its protection elicited in mice]","volume":"35","author":"Liang","year":"2019","journal-title":"Xi Bao Yu Fen. Zi Mian Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.biopha.2024.116264_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2020.151415","article-title":"Recombinant N-terminal outer membrane porin (OprF) of Pseudomonas aeruginosa is a promising vaccine candidate against both P. aeruginosa and some strains of Acinetobacter baumannii","volume":"310","author":"Bahey-El-Din","year":"2020","journal-title":"Int. J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116264_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4161\/hv.26565","article-title":"A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF\/I vaccine (IC43) in healthy volunteers","volume":"10","author":"Westritschnig","year":"2014","journal-title":"Hum. Vaccin Immunother."},{"issue":"1","key":"10.1016\/j.biopha.2024.116264_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13054-017-1601-9","article-title":"A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients","volume":"21","author":"Rello","year":"2017","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.biopha.2024.116264_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13054-020-2792-z","article-title":"Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial","volume":"24","author":"Adlbrecht","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.biopha.2024.116264_bib16","article-title":"Development of a Chimeric vaccine against Pseudomonas aeruginosa based on the Th17-stimulating epitopes of PcrV and AmpC","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116264_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00116-19","article-title":"A live Salmonella vaccine delivering PcrV through the type III secretion system protects against Pseudomonas aeruginosa","volume":"4","author":"Aguilera-Herce","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.biopha.2024.116264_bib18","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3389\/fmicb.2020.01971","article-title":"Type III secretion protein, PcrV, impairs Pseudomonas aeruginosa biofilm formation by increasing M1 macrophage-mediated anti-bacterial activities","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2024.116264_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molimm.2019.10.005","article-title":"Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models","volume":"116","author":"Ranjbar","year":"2019","journal-title":"Mol. Immunol."},{"issue":"41","key":"10.1016\/j.biopha.2024.116264_bib20","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1016\/j.vaccine.2021.08.103","article-title":"Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19","volume":"39","author":"Zhou","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.116264_bib21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.omtn.2023.04.029","article-title":"704\/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates","volume":"32","author":"Colombani","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.biopha.2024.116264_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24030603","article-title":"Hydrogels and their applications in targeted drug delivery","volume":"24","author":"Narayanaswamy","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2024.116264_bib23","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1021\/acs.biomac.2c00112","article-title":"Injectable slow-release hydrogel formulation of a plant virus-based COVID-19 vaccine candidate","volume":"23","author":"Nkanga","year":"2022","journal-title":"Biomacromolecules"},{"issue":"37","key":"10.1016\/j.biopha.2024.116264_bib24","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1016\/j.vaccine.2016.07.017","article-title":"A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice","volume":"34","author":"Yu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.116264_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110601","article-title":"Self-healing PEG-poly(aspartic acid) hydrogel with rapid shape recovery and drug release","volume":"185","author":"An","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2024.116264_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ijbiomac.2018.11.238","article-title":"Characterizations and immunostimulatory activities of a polysaccharide from Arnebia euchroma (Royle) Johnst. roots","volume":"125","author":"Bo","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2024.116264_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molimm.2019.12.003","article-title":"Interleukin-22 regulates interferon lambda expression in a mice model of pseudomonas aeruginosa pneumonia","volume":"118","author":"Broquet","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2024.116264_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583008","article-title":"Development of a broadly protective, self-adjuvanting subunit vaccine to prevent infections by Pseudomonas aeruginosa","volume":"11","author":"Das","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116264_bib29","article-title":"Pseudomonas aeruginosa: recent advances in vaccine development","volume":"10","author":"Killough","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2024.116264_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118919","article-title":"DNA vaccines against COVID-19: Perspectives and challenges","volume":"267","author":"Silveira","year":"2021","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.116264_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 mRNA COVID-19 vaccine: first approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.biopha.2024.116264_bib32","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jaci.2022.04.002","article-title":"Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity","volume":"149","author":"van Leeuwen","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116264_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11274-019-2739-1","article-title":"Metabolomic studies of Pseudomonas aeruginosa","volume":"35","author":"Mielko","year":"2019","journal-title":"World J. Microbiol Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116264_bib34","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000958","article-title":"Cell-free expression of the outer membrane protein OprF of Pseudomonas aeruginosa for vaccine purposes","volume":"4","author":"Mayeux","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.biopha.2024.116264_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104907","article-title":"Type 3 secretion system as an anti-Pseudomonal target","volume":"155","author":"Horna","year":"2021","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.biopha.2024.116264_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41541-023-00672-4","article-title":"Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.biopha.2024.116264_bib37","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2147\/IDR.S244081","article-title":"Protective Efficacy of the OprF\/OprI\/PcrV Recombinant Chimeric protein against Pseudomonas aeruginosa in the burned BALB\/c mouse model","volume":"13","author":"Fakoor","year":"2020","journal-title":"Infect. Drug Resist."},{"issue":"3","key":"10.1016\/j.biopha.2024.116264_bib38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jbm.a.34725","article-title":"An injectable and biodegradable hydrogel based on poly(\u03b1,\u03b2-aspartic acid) derivatives for localized drug delivery","volume":"102","author":"Lu","year":"2014","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.biopha.2024.116264_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jconrel.2014.06.027","article-title":"Designing and building the next generation of improved vaccine adjuvants","volume":"190","author":"Brito","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.116264_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijbiomac.2017.11.113","article-title":"Injectable hydrogels for delivering biotherapeutic molecules","volume":"110","author":"Mathew","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116264_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.coi.2013.03.011","article-title":"Th17 cell based vaccines in mucosal immunity","volume":"25","author":"Kumar","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116264_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1574-695X.2010.00764.x","article-title":"Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice","volume":"61","author":"Liu","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.biopha.2024.116264_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106033","article-title":"A chimeric vaccine targeting Pseudomonas aeruginosa virulence factors protects mice against lethal infection","volume":"178","author":"Korpi","year":"2023","journal-title":"Microb. Pathog."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:51:42Z","timestamp":1760104302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224001458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":43,"alternative-id":["S0753332224001458"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116264","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced protective efficacy of an OprF\/PcrV bivalent DNA vaccine against Pseudomonas aeruginosa using a hydrogel delivery system","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116264"}}